Related Experiment Video
Updated: Jun 21, 2026

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
Advances in technology for intracranial stereotactic radiosurgery
Arjun Sahgal1, Lijun Ma, Eric Chang
1Department of Radiation Oncology, Sunnybrook Odette Cancer Centre, the Princess Margaret Hospital, and the Joey Toby Tanenbaum family Gamma Knife Center, University of Toronto, Toronto, Ontario, Canada. Arjun.sahgal@rmp.uhn.on.ca
Technology in Cancer Research & Treatment
|August 4, 2009
Summary
Stereotactic radiosurgery (SRS) uses focused radiation for intracranial targets. Recent innovations are advancing non-invasive techniques, moving beyond traditional rigid head frames for improved patient treatment.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Medical Physics
Background:
- Stereotactic radiosurgery (SRS) is a precise, single-session radiation therapy targeting intracranial lesions.
- Accurate dose delivery traditionally relies on rigid stereotactic head frames for immobilization.
- Both Cobalt-60 (Gamma Knife) and linear accelerator (linac) technologies have been used for decades.
Purpose of the Study:
- To review recent technological advancements in stereotactic radiosurgery.
- To highlight innovations enabling non-invasive frame-based SRS.
- To discuss developments relevant to clinical practice.
Main Methods:
- Review of recent literature on stereotactic radiosurgery technologies.
- Analysis of innovations in patient immobilization and radiation delivery systems.
- Focus on advancements facilitating frame-less SRS.
Main Results:
- Significant progress has been made in developing non-invasive methods for patient head immobilization.
- Innovations in imaging and treatment planning enhance the accuracy of SRS delivery.
- New technologies are expanding the applicability and safety of SRS.
Conclusions:
- Technological advancements are making stereotactic radiosurgery more accessible and less invasive.
- The shift towards frame-less SRS represents a major innovation in neuro-oncology.
- Continued innovation promises further improvements in treating intracranial targets with SRS.
